Indication
Neuroectodermal Tumor
1 clinical trial
2 products
Clinical trial
Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor Adoptive T Cell Therapy During Recover From Myeloablative Chemotherapy and Hematopoietic Stem Cell TransplantationStatus: Active (not recruiting), Estimated PCD: 2020-03-28
Product
TTRNA-xALTProduct
TTRNA-DCs